Anti-ADAM30 antibodies are used in the immunodetection of the protein ADAM metallopeptidase domain 30. In humans, the canonical protein has a reported length of 790 amino acid residues and a mass of 88.9 kDa. Its subcellular localization is in the endosome. Up to 2 different isoforms have been reported for this protein. It is reported to be expressed in the brain neurons. ADAM30 is reported to play a role in lysosomal amyloid precursor protein (APP) processing by cleaving and activating CTSD/cathepsin D which leads to APP degradation. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include disintegrin and metalloproteinase domain-containing protein 30, a disintegrin and metalloproteinase domain 30, and svph4. ADAM30 gene orthologs have been reported in the mouse, rat and chimpanzee species. Some ADAM30 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.